Assessment of tophus size: A comparison between physical measurement methods and dual-energy computed tomography scanning

Journal of Clinical Rheumatology

Volumn 18, Issue 1, 2012, Pages 23-27

  Dalbeth, Nicola ^a   Aati, Opetaia ^a   Gao, Angela ^a   House, Meaghan ^a   Liu, Qiliang ^a   Horne, Anne ^a   Doyle, Anthony ^a   McQueen, Fiona M ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

dual energy computed tomography; gout; outcome measures; tophus

Indexed keywords

URATE;

ADULT; AGED; ARTICLE; BIOPHYSICAL EQUIPMENT; CALIPER; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; CONTROLLED STUDY; DUAL ENERGY COMPUTED TOMOGRAPHY; FEMALE; GOUT; HUMAN; INTERMETHOD COMPARISON; INTERRATER RELIABILITY; INTRARATER RELIABILITY; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REPRODUCIBILITY; TAPE MEASURE; THYROID WEIGHT; TOPHUS SIZE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GOUT; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; PHYSICAL EXAMINATION; RADIOGRAPHY, DUAL-ENERGY SCANNED PROJECTION; REPRODUCIBILITY OF RESULTS; URIC ACID;

EID: 84855199323     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0b013e31823e5cda     Document Type: Article

References (22)

1. Dalbeth N, Doyle A, Boyer L, et al. Development of a computed tomography method of scoring bone erosion in patients with gout: Validation and clinical implications. Rheumatology (Oxford). 2010;50:410-416.
2. Kumar S, Gow P. A survey of indications, results and complications of surgery for tophaceous gout. N Z Med J. 2002;115:U109.
3. Dalbeth N, Collis J, Gregory K, et al. Tophaceous joint disease strongly predicts hand function in patients with gout. Rheumatology (Oxford). 2007;46:1804-1807. (Pubitemid 350168295)
4. Dalbeth N, Clark B, Gregory K, et al. Mechanisms of bone erosion in gout: A quantitative analysis using plain radiography and computed tomography. Ann Rheum Dis. 2009;68:1290-1295.
5. Dalbeth N, Smith T, Nicolson B, et al. Enhanced osteoclastogenesis in patients with tophaceous gout: Urate crystals promote osteoclast development through interactions with stromal cells. Arthritis Rheum. 2008;58:1854-1865. (Pubitemid 351847541)
6. Becker MA, Schumacher HR, Benjamin KL, et al. Quality of life and disability in patients with treatment-failure gout. J Rheumatol. 2009;36:1041-1048.
7. Schumacher HR, Taylor W, Edwards L, et al. Outcome domains for studies of acute and chronic gout. J Rheumatol. 2009;36:2342-2345.
8. Dalbeth N, Schauer C, Macdonald P, et al. Methods of tophus assessment in clinical trials of chronic gout: A systematic literature review and pictorial reference guide. Ann Rheum Dis. 2011;70:597-604.
9. Boers M, Brooks P, Strand CV, et al. The OMERACT filter for outcome measures in rheumatology. J Rheumatol. 1998;25:198-199.
10. Dalbeth N, McQueen FM, Singh JA, et al. Tophus measurement as an outcome measure for clinical trials of chronic gout: Progress and research priorities. J Rheumatol. 2011;38:1458-1461.
11. Choi HK, Al-Arfaj AM, Eftekhari A, et al. Dual energy computed tomography in tophaceous gout. Ann Rheum Dis. 2009;68:1609-1612.
12. Abufayyah M, Nicolaou S, Eftekhari A, et al. Quantitative documentation of tophus volume change using dual energy computed tomography scans. Presented at the American College of Rheumatology Annual Scientific Meeting; 2010; Atlanta GA. Abstract number 2152.
13. Primak AN, Fletcher JG, Vrtiska TJ, et al. Noninvasive differentiation of uric acid versus non-uric acid kidney stones using dual-energy CT. Acad Radiol. 2007;14:1441-1447. (Pubitemid 350116647)
14. Stolzmann P, Kozomara M, Chuck N, et al. In vivo identification of uric acid stones with dual-energy CT: Diagnostic performance evaluation in patients. Abdom Imaging. 2010;35:629-635.
15. Wallace SL, Robinson H, Masi AT, et al. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum. 1977;20:895-900.
16. Perez-Ruiz F, Calabozo M, Pijoan JI, et al. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Rheum. 2002;47:356-360. (Pubitemid 34856121)
17. German DC. Practice tips: A simple measurement to monitor the size of gouty tophi and rheumatoid nodules. J Clin Rheumatol. 1997;3:45-46. (Pubitemid 27087954)
18. Dalbeth N, Clark B, Gregory K, et al. Computed tomography measurement of tophus volume: Comparison with physical measurement. Arthritis Rheum. 2007;57:461-465. (Pubitemid 46682534)
19. Becker MA, Schumacher HR Jr, Wortmann RL, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med. 2005;353:2450-2461. (Pubitemid 41781828)
20. Becker MA, Schumacher HR, MacDonald PA, et al. Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout. J Rheumatol. 2009;36:1273-1282.
21. Schumacher HR Jr, Becker MA, Wortmann RL, et al. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28-week, phase III, randomized, double-blind, parallel-group trial. Arthritis Rheum. 2008;59:1540-1548.
22. Schumacher HR Jr, Becker MA, Palo WA, et al. Tophaceous gout: Quantitative evaluation by direct physical measurement. J Rheumatol. 2005;32:2368-2372. (Pubitemid 41780649)